Stability and Plasticity of Regulatory T Cells
Stability and Plasticity of Regulatory T Cells
批准号:
7688823
负责人:
Abul K. Abbas
金额:
$19.73万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2014-04-30
关键词:
AddressAllograftingAntigensAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityAutomobile DrivingBiochemicalBiologicalBiological AssayBreedingCD4 Positive T LymphocytesCell Differentiation processCell LineageCell SeparationCell surfaceCellsChimeric ProteinsClinicalComplementDevelopmentDiseaseEffector CellEnvironmentEragrostisExposure toFigs - dietaryFlow CytometryFoundationsGene ExpressionGenerationsGenesGeneticGoalsHarvestHomeostasisHumanIL2RA geneImmuneImmunotherapyIn VitroInbred NOD MiceInflammationInflammatoryInsulin-Dependent Diabetes MellitusInterleukin-10Interleukin-17Knockout MiceKnowledgeMemoryMethodsMethylationMolecularMolecular ProfilingMouse StrainsMusNeuropilin-1Normal CellOvalbuminPathway interactionsPatientsPeripheralPeripheral Blood Mononuclear CellPhasePhenotypePhilosophyPlayPopulationProductionReactionRecording of previous eventsReporterRoleSignal PathwaySignal TransductionSorting - Cell MovementSpecificityStaining methodStainsStimulusSurfaceSystemT-LymphocyteT-Lymphocyte SubsetsTechnologyTestingTherapeuticThymus GlandTimeTransfectionTransgenic MiceTransgenic OrganismsTranslatingTretinoinautoreactivitybaseclinical phenotypecytokinedesignflugraft vs host diseasehealthy volunteerin vivoisletknock-downmolecular markermouse modelmutantnovelnovel strategiesperipheral bloodpreventprogramspromoterresearch studyresponsesmall hairpin RNAsuccesstranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this project is to define the plasticity and stability of regulatory T cells (Tregs) and the
possibility of converting effector cells to functional Tregs, as a prelude to cellular therapy. Our hypothesis is
that activated T cells go through a phase of transient Foxp3 expression that is a critical decision point, and
stable FoxpS expression is a key determinant of Treg stability. Our approach is to exploit mouse models to
address these questions in vivo and in vitro and to develop predictive phenotypic and molecular markers for
Treg stability, and use this information to define the stability of human Tregs and to genetically manipulate
human T cells in order to program their differentiation pathway. The following Specific Aims are proposed.
1. Functional and phenotypic plasticity of regulatory T cells (Tregs) and effector T cells (TefO.
In this Aim, we will generate antigen-specific natural (thymic) and adaptive (peripheral) Tregs using TCR
transgenic mice expressing fluorescent reporters for FoxpS and key cytokines (IFN-v, IL-17 and IL-10) and
different forms of antigen exposure. Purified Tregs will be transferred into normal recipients and exposed to
antigen with and without inflammatory stimuli, or transferred into recipients with active autoimmune reactions.
The cells will be followed for FoxpS and cytokine expression and surface phenotype by staining, and
unctional responses after sorting. Tregs will be isolated from healthy volunteers and patients with
autoimmune disease (initially T1D) and followed in vitro for conversion to effectors in the presence of
activating and inflammatory stimuli. A novel transgenic mouse strain that expresses a lineage marker of past
roxp3 expression will be used to examine the fates of these cells. The conversion of effector cells into Tregs
be examined using the same approaches.
2.'Biochemical basis of Treg stability and conversion. T cells will be examined under conditions of stability
and conversion for changes in surface phenotype, expression of Treg-specific genes, and methylation of the
:oxp3 locus. The functional consequence of transient FoxpS expression will be analyzed in mouse and
human cells using shRNA knockdowns and knockout mice. Attempts will be made to maintain the stability of
regs by expressing selected genes in human Tregs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
-
批准号:8078836
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:Abul K. Abbas
-
依托单位:
FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
-
批准号:8470530
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:Abul K. Abbas
-
依托单位:
FOCIS 2009 - 2013: The 9th through 13th Annual Meetings of the Federation of Clin
-
批准号:8278695
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2009
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7370244
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:8196707
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
13th International Congress of Immunology
-
批准号:7333178
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7994862
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7534357
-
项目类别:
-
资助金额:$38.63万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Interleukin-2 and autoimmune disease
-
批准号:7740173
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2007
-
负责人:Abul K. Abbas
-
依托单位:
Mechanisms of Peripheral CD4 T-cells tolerance
-
批准号:7215471
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2006
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:7176170
-
项目类别:
-
资助金额:$44.47万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodefiency and Autoimmunity
-
批准号:7011236
-
项目类别:
-
资助金额:$36.98万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:6911877
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodefiency and Autoimmunity
-
批准号:7270255
-
项目类别:
-
资助金额:$2.65万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:7346921
-
项目类别:
-
资助金额:$43.46万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
Immunodeficiency and Autoimmunity
-
批准号:7560013
-
项目类别:
-
资助金额:$43.47万
-
财政年份:2005
-
负责人:Abul K. Abbas
-
依托单位:
MECHANISMS OF T CELL TOLERANCE VS AUTOIMMUNITY IN VIVO
-
批准号:6616873
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2002
-
负责人:Abul K. Abbas
-
依托单位:
MEMORY T CELL DEVELOPMENT
-
批准号:6374228
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2000
-
负责人:Abul K. Abbas
-
依托单位:
MEMORY T CELL DEVELOPMENT
-
批准号:6740217
-
项目类别:
-
资助金额:$25.81万
-
财政年份:2000
-
负责人:Abul K. Abbas
-
依托单位:
MEMORY T CELL DEVELOPMENT
-
批准号:6532789
-
项目类别:
-
资助金额:$23.23万
-
财政年份:2000
-
负责人:Abul K. Abbas
-
依托单位:
海外基金